Drug which extends life is now in Northern Ireland
Pancreatic cancer patients in Northern Ireland have been granted access to a life-extending drug on the NHS for the first time.
Abraxane can offer patients the chance to live for another two months on average, and often much longer.
After a two-year wait, Abraxane was made available in England on the NHS in August.
The treatment, which is given to patients combined with standard chemotherapy, was already available on the NHS to patients in Wales and Scotland.
In Northern Ireland, pancreatic cancer has the lowest survival of the 20 most common cancers.
Anna Jewell from Pancreatic Cancer UK said: "We are absolutely delighted that eligible patients in Northern Ireland can now benefit from this treatment on the NHS.
"For years we have been campaigning alongside patients, families and other charities for this treatment to be made routinely available across the UK."